The mean age of AS patients was (35.0 ± 9.8) years.When the patients and control subjects were divided into different age groups (>40, 30-40, <30 years), the differences were not significantin terms of disease prevalence. The results also showed that the percentage of male patients is higher than that of females. There was no significant difference (P?0.05) between patients and controls in the distribution of males and females.Most of the patients had the disease for a period of 5 years or higher, with a disease severity of ? 2.1 and functional disability degree of I, II. The resultsshoweddifferent patterns of distribution for the three tested cytokines. A significant increase in the level of TNF-?, anon-significantincrease i

The effect of the antibiotic cefoperazone was examined. The experiment was conducted on white male mice. The experiment was divided into three groups, 11-12 mice were allocated to each group to conduct different experiments, It was injected Intraperitoneal into the groups for 7 consecutive days. The control group was given distilled water throughout the experimental days. The second group was given the antibiotic cefoperazone at a dose of 500?mg/kg/day. The third group was given the antibiotic cefoperazone 800?mg/kg/day. Cefoperazone affects blood components, causing a noticeable increase in the total number of blood cells, a slight increase in the number of red blood cells, and an increase in hemoglobin and hematocrit. It also caused an in

Background A case-control study was performed to explore eight pro-inflammatory and anti-inflammatory cytokines, namely interleukin (IL)-1α, IL-1Ra (IL-1 receptor antagonist), IL-12, IL-17A, IL-31, IL-33, CXCL10 (C-X-C motif chemokine ligand 10), and CXCL16, with the aim to understand their role in ankylosing spondylitis (AS) pathogenesis and evaluate their utility as markers to differentiate between diseased and healthy individuals. Among these cytokines, IL-31 and CXCL16 have not been well studied in AS. Patients and methods The study included 94 male patients with AS and 91 age-matched control males. Interleukin and chemokine levels were measured using ELISA kits. Results Serum levels of IL-17A, CXCL10, and CXCL16 were significantly ele